Taurolidine-Citrate locks significantly reduced the rate of CLABSI, particularly Gram negative organisms without adverse events” Clark et al (2018).
Abstract:
This study describes a successful, targeted intervention in central venous access device routine care, to decrease central line associated bloodstream infection (CLABSI). Taurolidine-Citrate locks significantly reduced the rate of CLABSI, particularly Gram negative organisms without adverse events.
You may also be interested in…
[rp4wp]
Reference:
Clark, J., Graham, N., Kleidon, T. and Ullman, A. (2018) Taurolidine-Citrate Line Locks Prevent Recurrent Central Line Associated Bloodstream Infection in Pediatric Patients. The Pediatric Infectious Disease Journal. September 10th. [epub ahead of print].
doi: 10.1097/INF.0000000000002191.